In stark contrast to reality, the American Academy of Pediatrics (AAP) - which is heavily funded by pharmaceutical companies, recommended on Tuesday that young children, including infants, receive the COVID-19 vaccine despite the fact that children are minimally impacted by the virus, the fact that the vaccine doesn't prevent one from contracting it, and that it largely only helps the elderly and medically fragile from severe cases.
According to the organization, all children ages 6-23 months should receive the COVID-19 vaccine - regardless of whether they have natural immunity from prior infection, unless they have a contraindication such as a history of severe allergic reaction to a vaccine ingredient.
While the recommendation is universal, the group said in a statement that their recommendation stems from infants and other children who are "at high risk for severe COVID-19."
As the Epoch Times notes further, the organization pointed, in part, to a paper it published that found that among children hospitalized for COVID-19 from fall 2022 to spring 2024, the majority of those younger than 2 had no underlying conditions.
No comments:
Post a Comment